Engaging. Relevant. Insightful.

We are lining up an incredible group of speakers to talk about current trends, opportunities, innovations and challenges facing our clinical trials community today – and in the future. Watch this space as we add to our line-up of speakers!

Click the images to read each speaker's full bio.

Hon. Nolan Quinn

Minister of Colleges, Universities, Research Excellence and Security

Simon Bacon

Co-Lead, International Behavioural Trials Network

Allison Brown,PhD

Senior Vice-President, Academic Engagement & Philanthropy, CCRM

Megan Bettle

Executive Director for Clinical Trials at the Canadian Institutes of Health Research (CIHR)

Dr. Ron Boch

Vice President, Biotechnology and Industry Affairs, BIOTECanada

Saliha Boumaza

Executive Director, Clinical Research , Merck

Andrew Costa

Assistant Professor & Canada Research Chair in Integrated Care for Seniors, Department of Clinical Epidemiology and Biostatistics, McMaster University; Research Director, St. Joseph’s Health System Centre for Integrated Care; Co-Founder & Executive Director, OnSPARK

Jennifer Cox

Legal Counsel and Manager, Research Contracts at the Ottawa Hospital Research Institute

Dr. PJ Devereaux

Director, Division of Perioperative Care at McMaster University; Senior Scientist and the Scientific Leader, Anesthesiology, Perioperative Medicine, and Surgical Research Group at the Population Health Research Institute; Professor, Departments of Health Research Methods, Evidence, and Impact (HEI) and Medicine, McMaster University

Maria Florez

Senior Consultant, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

Kenneth Getz

Executive Director & Professor, Tufts Center for the Study of Drug Development; Founder & Board Chair, CISCRP

Lisa Goos

Chief Operating Officer, CANTRAIN

Chris Hannay

Health Reporter, The Globe and Mail

Rob Henderson

President & CEO, BioTalent Canada

Munaza Jamil

Faculty, Applied Clinical Research Program, McMaster University; EDIA Lead, N2 Canada

Donna Janzen

Director, Regulatory Affairs Strategy and Policy, Roche Canada

Therese Lane

Board Member, Canadian Arthritis Patient Alliance (CAPA) and Arthritis Patient Partner

Margaret Loniewska

Rethink Breast Cancer Key Collaborator and Metastatic Breast Cancer Advisors Group Member

Jackie Manthorne

President & CEO, Cancer Care Survivor Network

Susan Marlin

President & CEO, Clinical Trials Ontario; Nominated Principal Applicant, CanReview

Kimberley McFadden

POPLAR Program Manager, Assistant Professor (Adjunct), Queen’s University

Cate Murray

President & CEO, Stem Cell Network

Ramy Nassar

AI & Emerging Technology Expert,former Head of Innovation for Mattel, and author of the AI Product Design Handbook

Monisha Nundy

National Operations Strategist, Site Management, Bayer Inc.

Kristen Pitzul

Director, Strategic Policy and Hospital-Enabled Research, Ontario Hospital Association

Alison Orth

Director,Clinical Trials British Columbia

Dr. Fahad Razak

Provincial Clinical Lead, Ontario Health; Co-Lead GEMINI ; Canada Research Chair in Data-Informed Healthcare Improvement, University of Toronto

Kevin Richards

Senior Director, Clinical Quality, AstraZeneca Canada

Eleana Rodriguez

Director of Research Legal for Clinical Trial Agreements (CTA), University Health Network (UHN)

Dr. Andy Smith

President & CEO, Sunnybrook Health Sciences Centre

Barry Stein

President & CEO, Colorectal Cancer Canada

Mina Tadrous

Associate Professor, Leslie Dan Faculty of Pharmacy, University of Toronto and Tier 2 Canada Research Chair in Pharmaceutical Policy and Real-world Evidence; Co-Director, Pharmaceutical Policy and Pharmacy Practice, Ontario Drug Policy Research Network (ODPRN); Adjunct Scientist, ICES

Charles Victor

Senior Director, Strategic Partnerships and Digital Services, ICES

Dr. Sowmya Viswanathan

Schroeder Arthritis Institute & Krembil Research Institute, University Health Network; Associate Professor, Institute of Biomedical Engineering & Department of Medicine, University of Toronto; Co-Director, Schroeder Arthritis Advanced Therapeutic Centre

Matt Westmore

Chief Executive of the UK’s Health Research Authority

Dr. Ryan Wiley

President, Shift Health

Dr. Kumanan Wilson

CEO & Chief Scientific Officer, Bruyère Health Research Institute; Physician Scientist, Ottawa Hospital; Chief Scientific Officer, CANImmunize Inc.

Dr. Bradly Wouters

Executive VP Science and Research, University Health Network

Stay tuned for more speakers!